Dry Eye Disease Market

Dry Eye Disease Market is valued around USD 3857.3 Million in 2025 and expected to reach USD 5320.04 Million by 2032 with the CAGR of 4.7% over the forecast period.

Increase in geriatric population and various environmental factors are the key drivers for Global Dry Eye Disease Market.

Key Companies Covered in the Dry Eye Disease Market

Dry Eye Disease Market report covers prominent players like,

• Allergan plc
• Altaire Pharmaceuticals
• Bausch Health Companies
• Johnson & Johnson
• Mitotech S.A.
• Santen Pharmaceutical Co.Ltd.
• Senju Pharmaceutical Co.Ltd.
• Sentiss Pharma Pvt. Ltd.
• Shire plc
• Similasan AG
• Sun Pharmaceutical Industries Ltd.
• Takeda Pharmaceutical Company
• Thea Pharmaceuticals Limited
• TRB Chemedica International SA
• Others

Dry Eye Disease Market Segmentation –

By Product Type 

• Artificial Tears
• Anti-inflammatory Drugs
• Punctal Plugs
• Secretagogue

By Distribution Channel

• Hospital Pharmacies
• Independent Pharmacies and Drug Stores
• Online Pharmacies

By Regional & Country Level:

• North America

  • U.S.
  • Canada

• Europe

  • U.K.
  • France
  • Germany
  • Italy

• Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia

• Latin America

  • Brazil
  • Mexico

• Middle East and Africa

  • GCC
  • Africa
  • Rest of Middle East and Africa

Market Analysis of Dry Eye Disease Market-

Dry eye disease market report published by the Brandessence Market Research and Consulting Pvt. Ltd. provides the detail information about dry eye disease market from various aspects. This report consists of drivers, restrains, Opportunities which help the market to grow over the analysis period and recent trends which support the growth of market. This report consists of regional segmentation with product type, distribution channel.

Dry eye disease is caused due to the lack of tears or lubrication in eyes which led to the burning sensation and redness in eyes. These tears provide lubrication and each blink spread tears evenly and provide nourishment to the eyes. When the production and drainage of tears are not balanced then it leads to the dry eye disease. This condition is most commonly occurs in older population and there are various environmental conditions which are responsible for such condition in young adults as well. The few symptoms experienced by the people suffering from dry eye disease are irritation, burning sensation, blurred vision and advanced stage may also lead to the vision impairment.

There are various factors driving the growth of the dry eye disease market, one of the major factors driving the growth of this market is increasing geriatric population. Due to the weakening of muscles and glands in geriatric people it is most common condition among them. As per Population Reference Bureau report, the number of Americans ages 65 and older is projected to more than double from 46 million today to over 98 million by 2060, and the 65-and-older age group’s share of the total population will rise to nearly 24 percent from 15 percent.  Furthermore, there are various research and development activities carried by major players which led to the development of novel drugs and devices for the treatment of this condition. Moreover, there is a constant increase in population and various other environmental factors which may affect the tear production which led to the dry eye disease. However, stringent regulations and high cost of dry eye disease are expected inhibit the growth of dry eye disease market over the forecast period.